​

Rithvik, A., Bhattacharjee, S., Illanad, G. H., Kumar, P., Javed, G., Karwasra, R., … Rasool, M. (2026). Majoon Ushba alleviated IL-17A sensitized keratinocyte ferroptosis via JAK-2-STAT-3 signaling axis and reversed imiquimod induced psoriasiform inflammation. Pharmaceutical Biology, 64(1), 575–598. https://doi.org/10.1080/13880209.2026.2654904

​

Kumari A and Rasool M (2026) Exploring the intricate relationship between IL-1β and IL-18 in the context of osteoarthritis. Front. Immunol. 17:1870390. doi: 10.3389/fimmu.2026.1870390

​

Mathew AA, Rithvik A and Rasool M (2026) Targeting the synovial engine: next-generation engineered immune cells to eradicate pathogenic FLS in rheumatoid arthritis, with safety-first, selective designs. Front. Immunol. 17:1890594. doi: 10.3389/fimmu.2026.1890594

​

Pillai V and Rasool M (2026) Meprin proteases in cutaneous homeostasis and psoriasis: pathophysiological mechanisms and therapeutic prospects. Front. Immunol. 17:1817338. doi: 10.3389/fimmu.2026.1817338

​

Morey MG, Illanad GH and Rasool M (2026) An intricate relationship between fibrosis and autoimmune diseases: a specific focus on unraveling its molecular, immunological, and epigenetic drivers. Front. Immunol. 17:1754620. doi: 10.3389/fimmu.2026.1754620

​

Rithvik A, Bhattacharjee S, Gupta MK, Sudandiradoss C, Wadud A and Rasool M (2025) Habbe Gule Aakh prevents glycolytic program and alleviates disease progression in a rheumatoid arthritis animal model. Front. Immunol. 16:1633061. doi: 10.3389/fimmu.2025.1633061​​​

​